查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433539

gRNA 市场规模、份额、趋势分析报告：按产品/服务、按 gRNA 类型、按应用、按最终用途、按地区、细分市场预测，2024-2030 年

gRNA Market Size, Share & Trends Analysis Report By Product & Services (Products, Custom gRNA Synthesis Services), By gRNA Type (Research-Use), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

gRNA 市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球gRNA市场规模预计将达到16.2亿美元，预计2024年至2030年复合年增长率为18.6%。

次世代定序(NGS) 的日益普及正在显着推动市场发展。随着NGS技术变得普及，它将为研究人员和科学家提供先进的基因组分析和操作能力。 NGS 能够对遗传物质进行高通量定序，从而能够快速且经济高效地查询整个基因组。这种效率对于 gRNA 应用至关重要，因为它有助于识别和检验用于遗传操作的目标基因。 NGS 技术提供了对基因组序列的准确和全面的了解。这种精确度对于设计高特异性 gRNA 至关重要，以确保在使用 CRISPR/Cas 系统的基因编辑过程中精确地标靶基因。

此外，生技和製药公司增加对研发活动的投资预计将在未来几年提振市场。使用者友好且负担得起的 gRNA 合成套件和服务的开发使各级研究人员更容易使用 CRISPR-Cas9 技术。 CRISPR-Cas9 新应用的持续发现推动了对 gRNA 的需求。

此外，新gRNA最终产品的推出可以促进技术创新，扩大参与者的市场范围，加速基因编辑技术的采用，并为整体市场的成长和进步做出贡献。例如，2023 年 10 月，着名的基因组工程解决方案提供者 Synthego 推出了 IND 支援 (INDe) gRNA。这项创新产品代表了基于 CRISPR 的细胞和基因疗法前临床开发平臺的重大进步。该产品在整个设计和製造过程中结合了全面的 IND 合规材料和材料，为研究人员提供精心设计的高品质 gRNA，用于 GLP 监管的临床前和 IND 支持的研究。包括文件。因此，它成为市场成长的驱动力。

gRNA 市场报告亮点

  • 按产品和服务划分，产品部门占收益占有率最大，2023年为73.4%。这些产品在基因编辑方面具有高精度、高效率和特异性，使其受到研究人员的欢迎，也是推动市场扩张的主要因素。
  • 按 gRNA 类型划分，研究领域在 2023 年占据了市场占有率。各研究机构正在进行的众多研究计画都需要研究级 gRNA，从而推动了这一领域的需求。
  • 从应用来看，基因组工程领域在2023年占据市场占有率。这种增长是由于对用于研究和治疗目的的先进遗传工具的需求不断增加。
  • 按最终用途划分，製药和生物技术公司在 2023 年占据市场占有率。製药和生物技术公司在精准医疗中采用 gRNA 将推动市场成长，因为它对于开发个人化治疗至关重要。
  • 由于该地区主要市场参与者的存在，北美在 2023 年以 52.6% 的销售份额在全球行业中占据主导地位。

目录

第一章调查方法与范围

第 2 章 gRNA 市场：执行摘要

  • 市场展望
  • 分段简介
  • 竞争形势概览

第 3 章 gRNA 市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 次世代定序的采用率增加
    • 蛋白质体学和基因组学研究和开发的成长
    • 个人化医疗的采用增加
  • 市场限制因素分析
    • 监管挑战
    • 脱靶效应与安全问题
  • 营商环境分析
    • 波特五力分析
    • PESTLE分析
  • COVID-19 分析

第四章 产品和服务的估算和趋势分析

  • gRNA市场：产品和服务的波动分析
  • 产品
    • 2018-2030 年产品市场估计与预测
    • gRNA最终产品
    • gRNA合成产品
  • 自订gRNA合成服务
    • 2018-2030 年自订gRNA 合成服务市场估计与预测

第五章 gRNA类型估计及趋势分析

  • gRNA市场：gRNA类型波动分析
  • 研究用途
  • GMP级

第 6 章 使用估算/趋势分析

  • gRNA市场：应用变异分析
  • 基因组工程
    • 2018-2030 年基因组工程市场收益估计与预测
  • 疾病模型研究
    • 2018-2030年疾病建模研究市场收益估算与预测
  • 功能基因体学
    • 2018-2030 年功能基因体学市场收益估计与预测
  • 磊晶
    • 磊晶市场收益估算与预测，2018-2030
  • 其他的
    • 2018-2030 年其他市场收益估计与预测

第七章 最终用途估算及趋势分析

  • gRNA 市场：最终用途变异分析
  • 製药和生物技术公司
  • 学术研究所
  • 首席行销长和首席研究官

第八章区域业务分析

  • 区域市场简介
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争形势

  • 公司分类
  • 策略规划
    • 获得
    • 产品/服务发布
    • 伙伴关係/协作
    • 其他的
  • 2023 年市场分析
  • 公司简介
    • Thermo Fisher Scientififc, Inc
    • Agilent Technologies, Inc.
    • System Biosciences, LLC.
    • Jena Bioscience GmbH
    • Merck KGaA
    • Azenta Life Sciences（Genewiz）
    • Takara Bio Inc.
    • Synbio Technologies
    • Revvity Inc（Horizon Discovery Ltd.）
    • Synthego
Product Code: GVR-4-68040-180-5

gRNA Market Growth & Trends:

The global gRNA market size is anticipated to reach USD 1.62 billion by 2030 and it is projected to grow at a CAGR of 18.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising adoption of Next-Generation Sequencing (NGS) is significantly boosting the market. As NGS technologies become more prevalent, they empower researchers and scientists with advanced capabilities for genomic analysis and manipulation. NGS enables high-throughput sequencing of genetic material, allowing for the rapid and cost-effective examination of entire genomes. This efficiency is crucial for gRNA applications, as it facilitates the identification and validation of target genes for genetic manipulation. NGS technologies provide a precise and comprehensive understanding of genomic sequences. This precision is vital for designing gRNAs with high specificity, ensuring accurate targeting of genes during the gene editing process using CRISPR/Cas systems.

Furthermore, the increasing investments by biotechnology and pharmaceutical companies for R&D activities are expected to fuel the market in the coming years. The development of user-friendly and affordable gRNA synthesis kits and services has made CRISPR-Cas9 technology more accessible to researchers of all levels. The continuous discovery of novel applications for CRISPR-Cas9 fuels the demand for gRNA.

Additionally, the launch of new gRNA final products can drive innovation, expand the market reach of players, and accelerate the adoption of gene editing technologies, contributing to the overall growth & advancement of the market. For instance, in October 2023, Synthego, a prominent provider of genome engineering solutions, launched IND-enabling (INDe) gRNAs. This transformative offering marks a significant advancement in the CRISPR-based cell and gene therapy preclinical pipeline. By providing researchers with high-quality gRNAs meticulously designed for GLP-regulated preclinical and IND-enabling studies, this product incorporates comprehensive IND-compliant materials and documentation throughout its design and production. Thus, it will drive the market growth.

gRNA Market Report Highlights:

  • On the basis of product & services, the product segment accounted for the largest revenue share of 73.4% in 2023. These products offer high accuracy, efficiency, and specificity in gene editing, making them popular among researchers is one of the primary drivers driving market expansion
  • On the basis of gRNA type, the research-use segment dominated the market share in 2023. A large number of research programs conducted across various research institutes demand research-grade gRNA is driving up demand for this segment
  • On the basis of application, the genome engineering segment dominated the market share in 2023. This growth can be attributed to the increasing demand for advanced genetic tools for research and therapeutic purposes
  • On the basis of end-use, the pharmaceutical & biotechnology companies segment dominated the market share in 2023. The adoption of gRNA in precision medicine by pharmaceutical and biotech companies fuels its market growth as it becomes integral to the development of personalized therapies
  • North America dominated the global industry in 2023 with a revenue share of 52.6% owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
  • 1.2. Information Analysis
  • 1.3. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. gRNA Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. gRNA Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Increase in adoption of Next-Generation Sequencing
    • 3.4.2. Growing R&D in proteomics and genomics
    • 3.4.3. Increasing adoption of personalized medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. Regulatory Challenges
    • 3.5.2. Off-Target Effects and Safety Concerns
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTLE Analysis
  • 3.7. COVID-19 Analysis

Chapter 4. Product & Services Estimates & Trend Analysis

  • 4.1. gRNA market: Product & Services Movement Analysis
  • 4.2. Products
    • 4.2.1. Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. gRNA Final Products
      • 4.2.2.1. gRNA Final Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. gRNA Synthesis Products
      • 4.2.3.1. gRNA Synthesis Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.2. gRNA Synthesis Kits
      • 4.2.3.2.1. gRNA Synthesis Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.3. Plasmids
      • 4.2.3.3.1. Plasmids Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.4. Others
      • 4.2.3.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Custom gRNA Synthesis Services
    • 4.3.1. Custom gRNA Synthesis Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. gRNA Type Estimates & Trend Analysis

  • 5.1. gRNA market: gRNA Type Movement Analysis
  • 5.2. Research-Use
    • 5.2.1. Research-Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. GMP-grade
    • 5.3.1. GMP-grade Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Application Estimates & Trend Analysis

  • 6.1. gRNA market: Application Movement Analysis
  • 6.2. Genome Engineering
    • 6.2.1. Genome Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Disease Model Studies
    • 6.3.1. Disease Model Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Functional Genomics
    • 6.4.1. Functional Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Epigenetics
    • 6.5.1. Epigenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. End-Use Estimates & Trend Analysis

  • 7.1. gRNA market: End-Use Movement Analysis
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Academic Research Institutes
    • 7.3.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. CMOs & CROs
    • 7.4.1. CMOs & CROs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America gRNA Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Target Disease Prevalence
      • 8.2.2.5. U.S. gRNA Market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. Canada gRNA Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Target Disease Prevalence
      • 8.3.2.5. UK gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. Germany gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.4. Spain
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. Spain gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. France gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. Italy gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Denmark gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Target Disease Prevalence
      • 8.3.8.5. Sweden gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Target Disease Prevalence
      • 8.3.9.5. Norway gRNA Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. Japan gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. China gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Target Disease Prevalence
      • 8.4.4.5. India gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Target Disease Prevalence
      • 8.4.5.5. South Korea gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Target Disease Prevalence
      • 8.4.6.5. Thailand gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Target Disease Prevalence
      • 8.4.7.5. Australia gRNA Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America gRNA Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. Brazil gRNA Market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Mexico gRNA Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. Argentina gRNA Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA gRNA Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Target Disease Prevalence
      • 8.6.2.5. South Africa gRNA Market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Target Disease Prevalence
      • 8.6.3.5. Saudi Arabia gRNA Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Target Disease Prevalence
      • 8.6.4.5. UAE gRNA Market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Target Disease Prevalence
      • 8.6.5.5. Kuwait gRNA Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Product/service launch
    • 9.2.3. Partnerships/Collaborations
    • 9.2.4. Others
  • 9.3. Market Position Analysis, 2023
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientififc, Inc
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Agilent Technologies, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. System Biosciences, LLC.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Jena Bioscience GmbH
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Merck KGaA
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Azenta Life Sciences (Genewiz)
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Benchmarking
      • 9.4.6.3. Strategic Initiatives
    • 9.4.7. Takara Bio Inc.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Synbio Technologies
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Revvity Inc (Horizon Discovery Ltd.)
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Synthego
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 4 Global gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 5 Global gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 6 Global gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 7 Global gRNA market, by Region, 2018 - 2030 (USD Million)
  • TABLE 8 North America gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 9 North America gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 10 North America gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 11 North America gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 12 North America gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 16 U.S. gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 17 Canada gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 18 Canada gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 19 Canada gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 20 Canada gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 21 Europe gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 22 Europe gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 23 Europe gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 24 Europe gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 25 Europe gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 26 UK gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 27 UK gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 28 UK gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 29 UK gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 30 Germany gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 31 Germany gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 32 Germany gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 33 Germany gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 34 France gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 35 France gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 36 France gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 37 France gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 38 Italy gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 39 Italy gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 40 Italy gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 41 Italy gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 42 Spain gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 43 Spain gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 44 Spain gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 45 Spain gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 46 Sweden gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 47 Sweden gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 48 Sweden gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 49 Sweden gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 50 Norway gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 51 Norway gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 52 Norway gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 53 Norway gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 54 Denmark gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 55 Denmark gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 56 Denmark gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 57 Denmark gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 58 Asia Pacific gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 59 Asia Pacific gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 60 Asia Pacific gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 61 Asia Pacific gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 62 Asia Pacific gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 63 Japan gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 64 Japan gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 65 Japan gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 66 Japan gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 67 China gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 68 China gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 69 China gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 70 China gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 71 India gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 72 India gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 73 India gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 74 India gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 75 Australia gRNA arket, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 76 Australia gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 77 Australia gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 78 Australia gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 79 South Korea gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 80 South Korea gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 81 South Korea gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 82 South Korea gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 83 Thailand gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 84 Thailand gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 85 Thailand gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 86 Thailand gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 87 Latin America gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 88 Latin America gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 89 Latin America gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 90 Latin America gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 91 Latin America gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 92 Brazil gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 93 Brazil gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 94 Brazil gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 95 Brazil gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 96 Mexico gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 97 Mexico gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 98 Mexico gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 99 Mexico gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 100 Argentina gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 101 Argentina gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 102 Argentina gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 103 Argentina gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 104 MEA gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 105 MEA gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 106 MEA gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 107 MEA gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 108 MEA gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 109 South Africa gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 110 South Africa gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 111 South Africa gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 112 South Africa gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 113 Saudi Arabia gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 114 Saudi Arabia gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 115 Saudi Arabia gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 116 Saudi Arabia gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 117 UAE gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 118 UAE gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 119 UAE gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 120 UAE gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 121 Kuwait gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 122 Kuwait gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 123 Kuwait gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 124 Kuwait gRNA market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market Research Process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 gRNA market Segmentation
  • FIG. 8 Market Snapshot, 2023
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Market Penetration & Growth Prospect Mapping, 2023
  • FIG. 15 Global gRNA market: Product & Services Movement Analysis
  • FIG. 16 Global gRNA market, For Products, 2018 - 2030 (USD Million)
  • FIG. 17 Global gRNA market, For gRNA Final Products, 2018 - 2030 (USD Million)
  • FIG. 18 Global gRNA market, For gRNA Synthesis Products, 2018 - 2030 (USD Million)
  • FIG. 19 Global gRNA market, For gRNA Synthesis Kits, 2018 - 2030 (USD Million)
  • FIG. 20 Global gRNA market, For Plasmids, 2018 - 2030 (USD Million)
  • FIG. 21 Global gRNA market, For Others, 2018 - 2030 (USD Million)
  • FIG. 22 Global gRNA market, For Custom gRNA Synthesis Services, 2018 - 2030 (USD Million)
  • FIG. 23 Global gRNA market: gRNA Type Movement Analysis
  • FIG. 24 Global gRNA market, For Research-Use, 2018 - 2030 (USD Million)
  • FIG. 25 Global gRNA market, For GMP-grade, 2018 - 2030 (USD Million)
  • FIG. 26 Global gRNA market: Application Movement Analysis
  • FIG. 27 Global gRNA market, For Genome Engineering, 2018 - 2030 (USD Million)
  • FIG. 28 Global gRNA market, For Disease Model Studies, 2018 - 2030 (USD Million)
  • FIG. 29 Global gRNA market, For Functional Genomics, 2018 - 2030 (USD Million)
  • FIG. 30 Global gRNA market, For Epigenetics, 2018 - 2030 (USD Million)
  • FIG. 31 Global gRNA market, For Others, 2018 - 2030 (USD Million)
  • FIG. 32 Global gRNA market: End-Use Movement Analysis
  • FIG. 33 Global gRNA market, For Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 34 Global gRNA market, For Academic Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 35 Global gRNA market, For CMOs & CROs, 2018 - 2030 (USD Million)
  • FIG. 36 Regional Marketplace: Key Takeaways
  • FIG. 37 Regional Outlook, 2023 & 2030
  • FIG. 38 Global gRNA market: Region Movement Analysis
  • FIG. 39 North America gRNA market, 2018 - 2030 (USD Million)
  • FIG. 40 U.S. gRNA market, 2018 - 2030 (USD Million)
  • FIG. 41 Canada gRNA market, 2018 - 2030 (USD Million)
  • FIG. 42 Europe gRNA market, 2018 - 2030 (USD Million)
  • FIG. 43 Germany gRNA market, 2018 - 2030 (USD Million)
  • FIG. 44 UK gRNA market, 2018 - 2030 (USD Million)
  • FIG. 45 France gRNA market, 2018 - 2030 (USD Million)
  • FIG. 46 Italy gRNA market, 2018 - 2030 (USD Million)
  • FIG. 47 Spain gRNA market, 2018 - 2030 (USD Million)
  • FIG. 48 Denmark gRNA market, 2018 - 2030 (USD Million)
  • FIG. 49 Sweden gRNA market, 2018 - 2030 (USD Million)
  • FIG. 50 Norway gRNA market, 2018 - 2030 (USD Million)
  • FIG. 51 Asia Pacific gRNA market, 2018 - 2030 (USD Million)
  • FIG. 52 Japan gRNA market, 2018 - 2030 (USD Million)
  • FIG. 53 China gRNA market, 2018 - 2030 (USD Million)
  • FIG. 54 India gRNA market, 2018 - 2030 (USD Million)
  • FIG. 55 Australia gRNA market, 2018 - 2030 (USD Million)
  • FIG. 56 South Korea gRNA market, 2018 - 2030 (USD Million)
  • FIG. 57 Thailand gRNA market, 2018 - 2030 (USD Million)
  • FIG. 58 Latin America gRNA market, 2018 - 2030 (USD Million)
  • FIG. 59 Brazil gRNA market, 2018 - 2030 (USD Million)
  • FIG. 60 Mexico gRNA market, 2018 - 2030 (USD Million)
  • FIG. 61 Argentina gRNA market, 2018 - 2030 (USD Million)
  • FIG. 62 Middle East And Africa gRNA market, 2018 - 2030 (USD Million)
  • FIG. 63 South Africa gRNA market, 2018 - 2030 (USD Million)
  • FIG. 64 Saudi Arabia gRNA market, 2018 - 2030 (USD Million)
  • FIG. 65 UAE gRNA market, 2018 - 2030 (USD Million)
  • FIG. 66 Kuwait gRNA market, 2018 - 2030 (USD Million)